The oncology community recently gathered at the European Society for Medical Oncology (ESMO) conference in Paris, where several exciting updates were shared related to NSCLC.

In a groundbreaking study, Dr. Charles Swanton's team showed that air pollution may contribute to development of lung cancer in people who don't have a smoking history. Particles in the air may accelerate development of cancer in people who already have underlying EGFR mutations, which can occur as part of the aging process. This study is exciting because it may help us understand why lung cancer happens in some individuals who don't have a history of smoking or other known risk factors.

Many studies presented at ESMO reinforce the importance of comprehensive biomarker testing to identify driver mutations and help determine the best treatments for patients.